US Stock MarketDetailed Quotes

CMMB Chemomab Therapeutics

Watchlist
  • 1.960
  • -0.020-1.01%
Close Feb 14 16:00 ET
  • 2.080
  • +0.120+6.12%
Post 19:38 ET
36.96MMarket Cap-2.09P/E (TTM)

Chemomab Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chemomab Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 14, 20242024/Q30.000 / 0.000--
Aug 21, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 14, 20242024/Q30.000 / 0.000--
Aug 21, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Chemomab Therapeutics Earnings Reports

  • Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 14, 2024 07:07 ET

  • Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Oct 11, 2024 16:04 ET

  • Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 21, 2024 07:05 ET

  • Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Jul 25, 2024 08:13 ET

    • Read more

    Trending Stocks

    Top Gaining Chinese Stocks Top Gaining Chinese Stocks
    No. Symbol % Chg
    PILOT
    831175
    +30.00%
    XINGANJIANG
    873167
    +29.99%
    Beijing Highlander Digital Technology
    300065
    +20.05%
    4
    Hangzhou Gaoxin Materials Technology
    300478
    +20.02%
    5
    Shijihengtong Technology
    301428
    +20.01%
    Log In for the Full List
    Unlock Now
    Investment Course
    Top 5 Industries for Stock Trading under Trump's Second Term
    Stocks & Industries to Watch Under Trump's Second Presidency
    With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
    Discussing
    Major earnings are approaching! What's ahead for Chinese stocks in 2025?
    Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More
    China's asset revaluation sparks debate: What are mooers buying?
    Monetary Policy: Navigating the Fed's Rate Cut Cycle
    Changing Fed policy is altering the market math for investors.